To determine the incidence of secondary cancers after bone marrow transplantation, we reviewed the records of all patients at our center who received allogeneic, syngeneic, or autologous transplants for leukemia (n = 1926) or aplastic anemia (n = 320). Thirty-five patients were given a diagnosis of secondary cancer between 1.5 months and 13.9 years (median, 1.0 year) after transplantation. Sixteen patients had non-Hodgkin's lymphomas, 6 had leukemias, and 13 had solid tumors (including 3 each with glioblastoma, melanoma, and squamous-cell carcinoma). There were 1.2 secondary cancers per 100 exposure-years during the first year after transplantation (95 percent confidence interval, 0.7 to 2.0). The rate declined to 0.4 (95 percent confidence interval, 0.2 to 0.7) after one year. The age-adjusted incidence of secondary cancer was 6.69 times higher than that of primary cancer in the general population. In a multivariate model, the predictors (and relative risks) of any type of secondary cancer were acute graft-versus-host disease treated with either antithymocyte globulin (relative risk, 4.2) or an anti-CD3 monoclonal antibody (13.6) and total-body irradiation (3.9). Two additional factors were associated with secondary non-Hodgkin's lymphomas: T-lymphocyte depletion of donor marrow (12.4) and HLA mismatch (3.8). We conclude that recipients of bone marrow transplantation have a low but significant risk of a secondary cancer, particularly non-Hodgkin's lymphoma.
Source Information
Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
This article has been cited by other articles:
Landgren, O., Gilbert, E. S., Rizzo, J. D., Socie, G., Banks, P. M., Sobocinski, K. A., Horowitz, M. M., Jaffe, E. S., Kingma, D. W., Travis, L. B., Flowers, M. E., Martin, P. J., Deeg, H. J., Curtis, R. E.
(2009). Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood
113: 4992-5001
[Abstract][Full Text]
Willemze, R., Dreyling, M., On behalf of the ESMO Guidelines Working Group,
(2009). Primary cutaneous lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol
20: iv115-iv118
[Full Text]
Bhatia, S., Francisco, L., Carter, A., Sun, C.-L., Baker, K. S., Gurney, J. G., McGlave, P. B., Nademanee, A., O'Donnell, M., Ramsay, N. K. C., Robison, L. L., Snyder, D., Stein, A., Forman, S. J., Weisdorf, D. J.
(2007). Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood
110: 3784-3792
[Abstract][Full Text]
Cohen, A., Rovelli, A., Merlo, D. F., van Lint, M. T., Lanino, E., Bresters, D., Ceppi, M., Bocchini, V., Tichelli, A., Socie, G.
(2007). Risk for Secondary Thyroid Carcinoma After Hematopoietic Stem-Cell Transplantation: An EBMT Late Effects Working Party Study. JCO
25: 2449-2454
[Abstract][Full Text]
Flynn, C. M., Kaufman, D. S.
(2007). Donor cell leukemia: insight into cancer stem cells and the stem cell niche. Blood
109: 2688-2692
[Abstract][Full Text]
Brunstein, C. G., Weisdorf, D. J., DeFor, T., Barker, J. N., Tolar, J., van Burik, J.-A. H., Wagner, J. E.
(2006). Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood
108: 2874-2880
[Abstract][Full Text]
Roman, E., Cooney, E., Harrison, L., Militano, O., Wolownik, K., Hawks, R., Foley, S., Satwani, P., Unal, E., Bhatia, M., Bradley, B., Del Toro, G., George, D., Garvin, J., van de Ven, C., Cairo, M. S.
(2005). Preliminary Results of the Safety of Immunotherapy with Gemtuzumab Ozogamicin following Reduced Intensity Allogeneic Stem Cell Transplant in Children with CD33+ Acute Myeloid Leukemia. Clin. Cancer Res.
11: 7164s-7170s
[Abstract][Full Text]
Bhatia, S., Robison, L. L., Francisco, L., Carter, A., Liu, Y., Grant, M., Baker, K. S., Fung, H., Gurney, J. G., McGlave, P. B., Nademanee, A., Ramsay, N. K. C., Stein, A., Weisdorf, D. J., Forman, S. J.
(2005). Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood
105: 4215-4222
[Abstract][Full Text]
Willemze, R., Jaffe, E. S., Burg, G., Cerroni, L., Berti, E., Swerdlow, S. H., Ralfkiaer, E., Chimenti, S., Diaz-Perez, J. L., Duncan, L. M., Grange, F., Harris, N. L., Kempf, W., Kerl, H., Kurrer, M., Knobler, R., Pimpinelli, N., Sander, C., Santucci, M., Sterry, W., Vermeer, M. H., Wechsler, J., Whittaker, S., Meijer, C. J. L. M.
(2005). WHO-EORTC classification for cutaneous lymphomas. Blood
105: 3768-3785
[Abstract][Full Text]
Rosenberg, P. S., Socie, G., Alter, B. P., Gluckman, E.
(2005). Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood
105: 67-73
[Abstract][Full Text]
Syrjala, K. L., Langer, S. L., Abrams, J. R., Storer, B., Sanders, J. E., Flowers, M. E. D., Martin, P. J.
(2004). Recovery and Long-term Function After Hematopoietic Cell Transplantation for Leukemia or Lymphoma. JAMA
291: 2335-2343
[Abstract][Full Text]
Thompson, M. P., Kurzrock, R.
(2004). Epstein-Barr Virus and Cancer. Clin. Cancer Res.
10: 803-821
[Abstract][Full Text]
Meij, P., van Esser, J. W. J., Niesters, H. G. M., van Baarle, D., Miedema, F., Blake, N., Rickinson, A. B., Leiner, I., Pamer, E., Lowenberg, B., Cornelissen, J. J., Gratama, J. W.
(2003). Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. Blood
101: 4290-4297
[Abstract][Full Text]
Sohaib, S A
(2002). Extrapulmonary complications of bone marrow transplantation. Imaging
14: 278-284
[Abstract][Full Text]
Tabbara, I. A., Zimmerman, K., Morgan, C., Nahleh, Z.
(2002). Allogeneic Hematopoietic Stem Cell Transplantation: Complications and Results. Arch Intern Med
162: 1558-1566
[Abstract][Full Text]
Khurshid, I, Anderson, L C
(2002). Non-infectious pulmonary complications after bone marrow transplantation. Postgrad. Med. J.
78: 257-262
[Abstract][Full Text]
Young, N. S.
(2002). Acquired Aplastic Anemia. ANN INTERN MED
136: 534-546
[Abstract][Full Text]
Wingard, J. R., Vogelsang, G. B., Deeg, H. J.
(2002). Stem Cell Transplantation: Supportive Care and Long-Term Complications. ASH Education Book
2002: 422-444
[Abstract][Full Text]
Berg, K. D., Brinster, N. K., Huhn, K. M., Goggins, M. G., Jones, R. J., Makary, A., Murphy, K. M., Griffin, C. A., Rosenblum-Vos, L. S., Borowitz, M. J., Nousari, H. C., Eshleman, J. R.
(2001). Transmission of a T-Cell Lymphoma by Allogeneic Bone Marrow Transplantation. NEJM
345: 1458-1463
[Full Text]
Bhatia, S., Louie, A. D., Bhatia, R., O'Donnell, M. R., Fung, H., Kashyap, A., Krishnan, A., Molina, A., Nademanee, A., Niland, J. C., Parker, P. A., Snyder, D. S., Spielberger, R., Stein, A., Forman, S. J.
(2001). Solid Cancers After Bone Marrow Transplantation. JCO
19: 464-471
[Abstract][Full Text]
Swinnen, L. J.
(2000). Post-transplant Lymphoproliferative Disorders: Implications for Acquired Immunodeficiency Syndrome-Associated Malignancies. J Natl Cancer Inst Monogr
2000: 38-43
[Abstract][Full Text]
Groves, F. D., Linet, M. S., Travis, L. B., Devesa, S. S.
(2000). Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995. JNCI J Natl Cancer Inst
92: 1240-1251
[Abstract][Full Text]
Koehne, G., Gallardo, H. F., Sadelain, M., O'Reilly, R. J.
(2000). Rapid selection of antigen-specific T lymphocytes by retroviral transduction. Blood
96: 109-117
[Abstract][Full Text]
Hopwood, P., Crawford, D. H
(2000). The role of EBV in post-transplant malignancies: a review. J. Clin. Pathol.
53: 248-254
[Full Text]
Socie, G., Curtis, R. E., Deeg, H. J., Sobocinski, K. A., Filipovich, A. H., Travis, L. B., Sullivan, K. M., Rowlings, P. A., Kingma, D. W., Banks, P. M., Travis, W. D., Witherspoon, R. P., Sanders, J., Jaffe, E. S., Horowitz, M. M.
(2000). New Malignant Diseases After Allogeneic Marrow Transplantation for Childhood Acute Leukemia. JCO
18: 348-348
[Abstract][Full Text]
Young, N. S., Abkowitz, J. L., Luzzatto, L.
(2000). New Insights into the Pathophysiology of Acquired Cytopenias. ASH Education Book
2000: 18-38
[Abstract][Full Text]
Kolb, H. J., Socie, G., Duell, T., Van Lint, M. T., Tichelli, A., Apperley, J. F., Nekolla, E., Ljungman, P., Jacobsen, N., van Weel, M., Wick, R., Weiss, M., Prentice, H. G., for the Late Effects Working Party of the European,
(1999). Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation. ANN INTERN MED
131: 738-744
[Abstract][Full Text]
Freedman, A. S., Neuberg, D., Mauch, P., Soiffer, R. J., Anderson, K. C., Fisher, D. C., Schlossman, R., Alyea, E. P., Takvorian, T., Jallow, H., Kuhlman, C., Ritz, J., Nadler, L. M., Gribben, J. G.
(1999). Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma. Blood
94: 3325-3333
[Abstract][Full Text]
Rowlings, P. A., Curtis, R. E., Passweg, J. R., Deeg, H. J., Socie, G., Travis, L. B., Kingma, D. W., Jaffe, E. S., Sobocinski, K. A., Horowitz, M. M.
(1999). Increased Incidence of Hodgkin's Disease After Allogeneic Bone Marrow Transplantation. JCO
17: 3122-3127
[Abstract][Full Text]
Curtis, R. E., Travis, L. B., Rowlings, P. A., Socie, G., Kingma, D. W., Banks, P. M., Jaffe, E. S., Sale, G. E., Horowitz, M. M., Witherspoon, R. P., Shriner, D. A., Weisdorf, D. J., Kolb, H.-J., Sullivan, K. M., Sobocinski, K. A., Gale, R. P., Hoover, R. N., Fraumeni, J. F. Jr, Deeg, H. J.
(1999). Risk of Lymphoproliferative Disorders After Bone Marrow Transplantation: A Multi-Institutional Study. Blood
94: 2208-2216
[Abstract][Full Text]
Bodo, I., Peters, M., Radich, J. P., Hess, J., Blinder, M., Watson, M. S., Van Rheeden, R., Natarajan, S., Lowell, J. A., Brown, R., DiPersio, J., Adkins, D.
(1999). Donor-Derived Acute Promyelocytic Leukemia in a Liver-Transplant Recipient. NEJM
341: 807-813
[Full Text]
Young, N. S.
(1999). Acquired Aplastic Anemia. JAMA
282: 271-278
[Full Text]
Pepperl, S., Benninger-Doring, G., Modrow, S., Wolf, H., Jilg, W.
(1998). Immediate-Early Transactivator Rta of Epstein-Barr Virus (EBV) Shows Multiple Epitopes Recognized by EBV-Specific Cytotoxic T Lymphocytes. J. Virol.
72: 8644-8649
[Abstract][Full Text]
Mach-Pascual, S., Legare, R. D., Lu, D., Kroon, M., Neuberg, D., Tantravahi, R., Stone, R. M., Freedman, A. S., Nadler, L. M., Gribben, J. G., Gilliland, D. G.
(1998). Predictive Value of Clonality Assays in Patients With Non-Hodgkin's Lymphoma Undergoing Autologous Bone Marrow Transplant: A Single Institution Study. Blood
91: 4496-4503
[Abstract][Full Text]
Deeg, H. J., Socie, G.
(1998). Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers. Blood
91: 1833-1844
[Full Text]
de Lima, M., Strom, S. S., Keating, M., Kantarjian, H., Pierce, S., O'Brien, S., Freireich, E., Estey, E.
(1997). Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work. Blood
90: 4719-4724
[Abstract][Full Text]
Kersey, J. H.
(1997). Fifty Years of Studies of the Biology and Therapy of Childhood Leukemia. Blood
90: 4243-4251
[Full Text]
Curtis, R. E., Rowlings, P. A., Deeg, H. J., Shriner, D. A., Socie, G., Travis, L. B., Horowitz, M. M., Witherspoon, R. P., Hoover, R. N., Sobocinski, K. A., Fraumeni, J. F., Boice, J. D., Schoch, H. G., Sale, G. E., Storb, R., Travis, W. D., Kolb, H.-J., Gale, R. P., Passweg, J. R.
(1997). Solid Cancers after Bone Marrow Transplantation. NEJM
336: 897-904
[Abstract][Full Text]
Koeberl, D. D., Alexander, I. E., Halbert, C. L., Russell, D. W., Miller, A. D.
(1997). Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA
94: 1426-1431
[Abstract][Full Text]
Previous
